Study of two experimental drugs for advanced prostate cancer
Part of Cancer clinical trials.
This study tests a combination of two experimental drugs, HRS-2189 and HRS-5041, for men with advanced prostate cancer that has spread and is no longer responding to standard treatments. The goal is to see if the combination is safe and effective in controlling tumor growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male and between 18 and 80 years old.
- You have a type of prostate cancer called adenocarcinoma that has spread to other parts of the body (metastatic).
- Your prostate cancer is getting worse despite previous treatments.
- You are generally able to care for yourself (ECOG score 0 or 1).
- You have not had brain metastases, serious bone problems, or major heart issues recently.
- You can swallow pills and have adequate liver, kidney, and blood function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two experimental drugs, HS-20093 and HRS-5041, for men with advanced prostate cancer that has stopped responding to standard hormone therapy. The goal is to see if this new treatment can help control the cancer when other treatments have stopped working.
This Phase 1 trial tests HRS-5041 in people with metastatic castration-resistant prostate cancer (prostate cancer that keeps growing despite lower testosterone). It aims to see if the drug can be given safely and whether it may help control the cancer after prior standard treatments.
This trial tests a new drug, HRS-4357, against standard treatments for men with a specific type of advanced prostate cancer that has spread and no longer responds to hormone therapy. It aims to see if the new drug works better.
This trial tests a new tablet called HRS-5041 combined with other anti-cancer treatments for men with advanced prostate cancer that has not responded to previous therapies. It aims to see how well the combination works and if it is safe.
This study tests a new oral tablet (HRS-7525) for men with advanced prostate cancer that has spread. It aims to see if the drug is safe and effective, and may offer a new treatment option for those who have not responded to standard therapies.
This study tests two new experimental drugs (HRS-4642 and SHR-A2102) given together to people with advanced solid tumors. The goal is to see if the combination is safe and helps shrink tumors or slow their growth.
Hear when a new Prostate Cancer Metastatic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.